$TRUE bollies are pinching tightNASDAQ:TRUE bollies are pinching tight, looking for a breakout to the upside here shortly, volume has been on the rise.
−0.2595USD
−2.80 MUSD
899.78 K
About Treatment.com AI Inc.
Sector
Industry
CEO
Essam Hamza
Website
Headquarters
Bloomington
Founded
2016
ISIN
CA8949421017
FIGI
BBG0113J0G78
Treatment.com AI, Inc. engages in the research, development, and business development of consumer health services delivered by mobile app technology. It offers the AI transactional platform MERLIN, capable of aggregating, curating and assessing existing and emerging medical knowledge, including primary care, genetics, cancer and heart treatments, and chronic and infectious diseases. The company was founded by John Fraser in 2016 and is headquartered in Bloomington, MN.
$TREIF on watchOTC:TREIF on watch as volume has started to kick in the last few days and a notable uptrend has formed on the daily chart.
AI breaking the marketsTREIF is a service provider bringing AI advisors to the medical industry. The time will tell to what degree will be its early versions useful and it doesn't have the equipment a real doctor has. But I can see how it could sort out symptoms and give medical advice for common mild health problems fair
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of TREIF is 0.5270 USD — it has increased by 0.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Treatment.com AI Inc. stocks are traded under the ticker TREIF.
TREIF stock is 54.29% volatile and has beta coefficient of −4.07. Check out the list of the most volatile stocks — is Treatment.com AI Inc. there?
Yes, you can track Treatment.com AI Inc. financials in yearly and quarterly reports right on TradingView.
TREIF stock has fallen by 0.92% compared to the previous week, the month change is a 20.26% rise, over the last year Treatment.com AI Inc. has showed a 112.50% increase.
TREIF net income for the last quarter is −615.51 K USD, while the quarter before that showed −217.32 K USD of net income which accounts for −183.23% change. Track more Treatment.com AI Inc. financial stats to get the full picture.
Today Treatment.com AI Inc. has the market capitalization of 3.51 M, it has decreased by 3.16% over the last week.
No, TREIF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TREIF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Treatment.com AI Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Treatment.com AI Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Treatment.com AI Inc. stock shows the buy signal. See more of Treatment.com AI Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.